HEOR and Real-World Evidence Explained: Proving a Drug’s Value, Why HEOR Professionals Sometimes Need to Think Like a Sales Person
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
HEOR and Real-World Evidence Explained: Proving a Drug’s Value, Why HEOR Professionals Sometimes Need to Think Like a Sales Person
-
ナレーター：
-
著者：
Clinical trials prove a drug works. HEOR and real-world evidence prove it's worth it.
From formulation chemist to clinical trials, in vitro diagnostics and global medical affairs, Rohan Parekh, PhD, MS, PharmD, has seen data from every side of the lab bench. As Senior Manager, Global Medical Affairs at Merz Aesthetics, he joins Will Soliman on the ACMA Medical Affairs x MSL Power Play Series to break down Health Economics and Outcomes Research (HEOR), one of the fastest-growing and most in-demand areas of medical affairs, and how data turns into value for patients, payers, and pharma.
Together they unpack:
What real-world evidence (RWE) is, and how it differs from clinical trial data
How HEOR supports drug pricing, cost-effectiveness and market access
How real-world data can open the door to new indications
How companies are restructuring HEOR teams on tighter budgets
Where HEOR is headed in medical affairs, commercial and marketing
You'll find out:
How a simple blood test for brain injury reveals the true value of HEOR
What GLP-1 drugs like Ozempic and Zepbound mean for the future of real-world evidence
The real difference between an HEOR liaison and an MSL, and who each one calls on
Why HEOR professionals sometimes have to think like a salesperson
Where patient frustration with insurance denials and prior authorizations fits in
How Rohan made the jump from the lab into medical affairs
Whether you're an MSL, a medical affairs professional exploring HEOR, or a pharmacist, PhD, MD, or scientist breaking into the pharmaceutical industry, this episode shows you why HEOR is becoming indispensable across life sciences.
Follow the ACMA Medical Affairs x MSL Power Play Series so you never miss an episode, and share this one with a colleague curious about HEOR.
Exclusive listener offer: Get 30% OFF ACMA's premier Medical Science Liaison board certification programs, the Board Certified Medical Affairs Specialist (BCMAS) and the Medical Science Liaison Board Certified Biologics and Biosimilars Specialist (BCBBS), rated #1 by Industry Insiders. Use code PODCAST30.
Follow Will Soliman on:
LinkedIn
willsoliman.com
Follow Accreditation Council for Medical Affairs (ACMA)
LinkedIn
Medical Affairs Specialist
HEOR, health economics and outcomes research, real-world evidence, RWE, real-world data, HEOR liaison, outcomes research, market access, payers, cost-effectiveness, drug pricing, value demonstration, GLP-1, Ozempic, Zepbound, prior authorization, Medical Affairs, Medical Science Liaison, MSL, global medical affairs, pharma careers, PhD to industry, BCMAS, BCBBS, board certification, Accreditation Council for Medical Affairs